- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1747-1028
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Principles of dormancy evident in high-grade serous ovarian cancer ; volume:17 ; number:1 ; day:23 ; month:3 ; year:2022 ; pages:1-11 ; date:12.2022
Cell division ; 17, Heft 1 (23.3.2022), 1-11, 12.2022
- Urheber
-
Shepherd, Trevor G.
Dick, Frederick A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13008-022-00079-y
- URN
-
urn:nbn:de:101:1-2022061421414796175374
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:16 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shepherd, Trevor G.
- Dick, Frederick A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
High-grade serous ovarian cancer: the clone wars
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Evident
Evident
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
No evidence for PALB2 methylation in high-grade serous ovarian cancer
Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma
High-grade serous ovarian cancer: the clone wars
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Evident
Evident
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
No evidence for PALB2 methylation in high-grade serous ovarian cancer
Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma
High-grade serous ovarian cancer: the clone wars
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Evident
Evident
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
No evidence for PALB2 methylation in high-grade serous ovarian cancer
Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer